Clinical trials: Electric Countershock
Atrial Fibrillation
Atrial Fibrillation/Sinus Rhythm Before and After Cardioversion
This study´s aim is to collect scientific data about patients with atrial inflammation by two principles of sensors measuring congestive heart failure.
- Trial name
- NCT01779674
- Where
- Germany
- Volunteers
- 25 people
- Sponsor
- RWTH Aachen University
Ventricular Fibrillation, Cardiac Arrest
SmartCPR Trial: An Analysis of a Waveform-Based Automated External Defibrillation (AED) Algorithm on Survival From Out-of-Hospital Ventricular Fibrillation
This study is designed to examine the impact of an available technology within an automated external defibrillator (AEDs) to improve survival following out-of-hospital cardiac arrest for patients presenting in ventricular…
- Trial name
- SmartCPR (NCT00535106)
- Testing
- Automated external defibrillator (Philips FR2+ AED), SmartCPR, Delayed defibrillation
- Where
- 2 sites in United States, United Kingdom
- Volunteers
- 900 people
- Sponsor
- New York City Fire Department
Blood Pressure
Predicting Blood Pressure in Patients Following Defibrillation
During tachyarrhythmias, central venous pressures increases while arterial blood pressure (BP) decreases. The result is mixed messages to the central nervous system.
- Trial name
- NCT02686307
- Testing
- ICD Implant
- Volunteers
- 33 people
- Sponsor
- University of Utah
Cardiac Pacing, Electric Countershock
Follow-up of Patients With Implantable Cardioverter Defibrillators by Home Monitoring (ANVITE)
Patients with implantable cardioverter defibrillators (ICDs) should undergo regular device follow-ups every 3 months, to verify proper ICD function.
- Conditions
- Cardiac Pacing, Electric Countershock, Ventricular Tachyarrhythmia
- Trial name
- ANVITE (NCT00858559)
- Testing
- Implantable cardioverter defibrillator with Home Monitoring function, Standard implantable cardioverter defibrillator
- Where
- Germany
- Volunteers
- 110 people
- Sponsor
- Biotronik SE & Co. KG
Ventricular Tachycardia, Ventricular Fibrillation, Heart Failure
Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following
The COGENT-4 Field Following Study will evaluate the clinical performance of the Boston Scientific TELIGEN 100 HE Implantable Cardioverter Defibrillator (ICD), the COGNIS 100 HE Cardiac Resynchronization Therapy ICD (CRT-D)…
- Trial name
- Cogent-4 (NCT00606710)
- Testing
- Cognis 100-D, Teligen DR, VR 100 HE
- Where
- 4 sites in Denmark, Israel
- Volunteers
- 450 people
- Sponsor
- Guidant Corporation
Atrial Fibrillation Paroxysmal
Refralon Versus Amiodarone for Cardioversion of Paroxysmal Fibrillation and Atrial Flutter
Patients hospitalized with paroxysmal atrial fibrillation and flutter to restore sinus rhythm will be randomized into two groups: one will be cardioversion with refralon and the other with amiodarone
- Trial name
- NCT05445297
- Testing
- Pharmacological cardioversion with Amiodarone, Pharmacological cardioversion with Refralon
- Where
- Russia
- Volunteers
- 60 people
- Sponsor
- National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Current or Recent History of Atrial Fibrillation
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
This study is being done to compare the effects of bucindolol hydrochloride (bucindolol) to metoprolol succinate (Toprol-XL) on the recurrence of symptomatic atrial fibrillation/atrial flutter in patients with heart failure who…
- Trial name
- GENETIC-AF (NCT01970501)
- Testing
- bucindolol hydrochloride, metoprolol succinate
- Where
- 97 sites in United States, Canada and 4 more
- Volunteers
- 267 people
- Sponsor
- ARCA Biopharma, Inc.
Cardiac Arrest
Transthoracic Incremental Monophasic Versus Biphasic by Emergency Responders (TIMBER)
The study compares the effectiveness of two fully approved shock waveforms (monophasic and biphasic shock) commonly used to defibrillate (shock) patients with out-of-hospital cardiac arrest due to a highly lethal rhythm problem…
- Trial name
- NCT00101881
- Testing
- Defibrillation (biphasic versus monophasic shock)
- Where
- United States
- Volunteers
- 168 people
- Sponsor
- University of Washington
Out of Hospital Cardiac Arrest, Ventricular Fibrillation
Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest
Some of the patients affected by Out-of-hospital cardiac arrest (OHCA) with ventricular fibrillation (VF)/ventricular tachycardia (VT) do not respond to initial defibrillation.
- Conditions
- Out of Hospital Cardiac Arrest, Ventricular Fibrillation, Defibrillation, CPR
- Trial name
- DOUBLE D (NCT07174986)
- Testing
- Double sequential defibirllation, Standard defibrillation
- Where
- 14 sites in Netherlands, Spain and 1 more
- Volunteers
- 916 people
- Sponsor
- Gabriel Riva
Ventricular Fibrillation
DOuble SEquential External Defibrillation for Refractory VF Pilot Study
Despite significant advances in resuscitation efforts, there are some patients who remain in refractory ventricular fibrillation (VF) during out-of-hospital cardiac arrest.
- Trial name
- DOSE-VF (NCT03249948)
- Testing
- Vector change defibrillation, Double-sequential defibrillation
- Where
- 4 sites in Canada
- Volunteers
- 173 people
- Sponsor
- Sunnybrook Health Sciences Centre
Heart Failure, Congestive, Tachycardia, Ventricular
Right Ventricular Defibrillation Lead Select Site Study
This study will compare single coil right ventricular defibrillation leads for implanted cardioverter/defibrillators (ICDs) in the apical and high septal locations.
- Trial name
- NCT00385749
- Testing
- RV apical vs RV septal defibrillation threshold testing
- Where
- United States
- Volunteers
- 98 people
- Sponsor
- Associates in Cardiology, PA
Cardiopulmonary Resuscitation (CPR), Electrical Shock
Effect of Electrically Insulated Gloves on ROSC Time, End-tidal CO₂ Response, Survival and Morbidity in Uninterrupted CPR
Cardiopulmonary arrest is the sudden cessation of spontaneous breathing and circulation due to various causes. Cardiopulmonary resuscitation (CPR) is the set of decisions and procedures encompassing all efforts aimed at restoring…
- Conditions
- Cardiopulmonary Resuscitation (CPR), Electrical Shock, Defibrillation
- Trial name
- IG-CPR (NCT07299188)
- Testing
- HANDS ON BUT OFF DEFIBRILLATION
- Where
- Turkey (Türkiye)
- Volunteers
- 32 people
- Sponsor
- Izmir Katip Celebi University
Atrial Fibrillation (AF), Atrial Fibrillation
Restoring Sinus Rhythm Using Dual-Shock Technique in Patients With Atrial Fibrillation
The goal of this clinical trial is to assess the efficacy and acute safety of the dual electrical cardioversion (ECV) technique compared with the conventional ECV in patients with persistent atrial fibrillation.
- Trial name
- DUAL-SHOCK (NCT07560644)
- Testing
- Conventional Electrical Cardioversion, Dual-shock Electrical Cardioversion
- Volunteers
- 177 people
- Sponsor
- Martín Negreira Caamaño, MD, PhD
Heart Disease, Congestive Heart Failure
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
Atrial fibrillation (AF) and heart failure (HF) are two common heart conditions that are encountered with an increase in death and suffering.
- Conditions
- Heart Disease, Congestive Heart Failure, Atrial Fibrillation
- Trial name
- RAFT-PermAF (NCT01994252)
- Testing
- Optimal Medical therapy plus ICD, Optimal Medical therapy plus CRT/ICD
- Where
- 15 sites in Canada
- Volunteers
- 200 people
- Sponsor
- Ottawa Heart Institute Research Corporation
Post-operative Atrial Fibrillation POAF
The DefiPace Study
Prospective, non-interventional, multi-center, international registry in two phases in consecutive patients undergoing elective cardiac surgery. The DefiPace registry is designed in two phases 1.
- Trial name
- Defipace (NCT04804748)
- Testing
- No intervention
- Where
- 10 sites in Austria, Germany
- Volunteers
- 450 people
- Sponsor
- Institut für Pharmakologie und Präventive Medizin
Atrial Fibrillation, Atrial Flutter
Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter
Atrial fibrillation is a condition in which the heart's upper chambers, the atria, contract at an abnormally rapid rate. It is a common type of arrhythmia, and occurs in 1-2% of the general population.
- Trial name
- NCT01818583
- Testing
- Potassium chloride, Glucose 50 MG/ML
- Where
- Norway
- Volunteers
- 143 people
- Sponsor
- Diakonhjemmet Hospital
Atrial Fibrillation, Electrocardiography
CArdioversion of Short Duration Atrial Fibrillation
The study is aimed at testing the hypothesis whether atrial fibrillary rate (AFR), as a measure of atrial electrical remodeling assessed from surface ECG, is predictive of sinus rhythm maintenance after electrical cardioversion.
- Conditions
- Atrial Fibrillation, Electrocardiography, Electrical Remodeling
- Trial name
- CASAF (NCT02112318)
- Where
- 3 sites in Canada, Sweden
- Volunteers
- 32 people
- Sponsor
- Region Skane
Atrial Fibrillation
A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)
This Phase 2 study is a two-stage, serial cohort dose escalation and expansion study of a single 30-minute (IV) infusion of HBI-3000 for the conversion of patients with recent-onset atrial fibrillation (AF).
- Trial name
- NCT04680026
- Testing
- HBI-3000
- Where
- 14 sites in United States, Bosnia and Herzegovina and 3 more
- Volunteers
- 150 people
- Sponsor
- HUYABIO International, LLC.
Arrhythmia, Heart Arrest
Public Access Defibrillation (PAD) Community Trial
To measure survival to hospital discharge of patients with out-of-hospital cardiac arrest in community units (e.g., apartment or office buildings, gated communities, sports venues, senior centers, shopping malls) served by…
- Conditions
- Arrhythmia, Heart Arrest, Heart Diseases, Myocardial Infarction
- Trial name
- NCT00004560
- Testing
- defibrillator
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
Atrial Fibrillation
FINnish CardioVersion Study II
This is a retrospective multi-center patient cohort study investigating patients with persistent atrial fibrillation (AF) and elective cardioversion (ECV).
- Trial name
- FinCV2 (NCT02850679)
- Where
- Finland
- Volunteers
- 1,342 people
- Sponsor
- University of Turku